MOR (MorphoSys Corp) Long-Term Debt

Public company logo of MorphoSys Corporation (MOR)

MorphoSys AG (MOR) is protected by unique patents for tumor therapy and significant influence within Western government agencies, which blocks competitor access. Financial stability is confirmed by a deal with a Swiss behemoth, and the value chart indicator stands at 0.00. The business relies on its own antibody libraries, creating indispensable oncology drugs in alliance with global corporations.

MOR morphosys.com Company Long-Term Liabilities (07/04/2022 - 08/10/2024)

MorphoSys Corp (MOR) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Quotes morphosys.com|MOR - Analyst Consensus Forecast
- market capitalization data:
Market Value MorphoSys|MOR - Total Company Value
- book capitalization data:
Accounting Value of a Share MorphoSys|MOR - Company Net Assets|Market Value to Book Value morphosys.com|MOR - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio MorphoSys AG|MOR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital MorphoSys Corporation|MOR - Company Debts|Debt to Net Assets Ratio MorphoSys|MOR - Company Long-Term Debts|Short-Term Debt MorphoSys
Comprehensive company analysis:MOR (morphosys.com)
Mass-produced product of MorphoSys Corp

Fundamental asset selection requires a rigorous analysis of the liability structure within financial statements. Long-term debt measures the volume of credit resources with maturities exceeding one year, determining the issuer's financial stability. For MorphoSys AG (MOR), these funds are critical for the robotization of antibody screening laboratories. Investments in testing automation require long-term capital. By analyzing the company's long-term debt position, an investor distinguishes systemic leverage from market noise.

Direct competitors

Company Long-Term Liabilities beigene.com ONC|HALO (Halozyme) - Company Long-Term Debts|RVMD: Long-Term Debt|Company Long-Term Debt Ascentage AAPG|Company Long-Term Loans and Borrowings CG Oncology Therapeutics|URGN - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings bicara.com|Company Long-Term Debts PSNL (Personalis)|Company Long-Term Liabilities Erasca Inc ERAS|Company Long-Term Liabilities DCTH (Delcath)|Y-mAbs Corp - Company Long-Term Debts|Company Long-Term Debt Aura Biosciences, Inc. (AURA)|CADL - Company Long-Term Loans and Borrowings|Company Long-Term Debts ARAY|SLS (SELLAS Life Sciences Group) - Long-Term Debt|Company Long-Term Debt ACTU|Company Long-Term Liabilities CTOR|TuHURA Biosciences, Inc. - Company Long-Term Debt|Long-Term Debt TARA (protaratx.com)|Company Long-Term Debt Fate Therapeutics|Aadi Bioscience, Inc. - Company Long-Term Loans and Borrowings|Company Long-Term Debt TScan|CSBR - Long-Term Liabilities|Company Long-Term Debts xbiotech.com XBIT|CVM (CEL-SCI) - Company Long-Term Loans and Borrowings|Company Long-Term Debt OSTX (OS Therapies)|Long-Term Debt RADX|ARTV (Artiva Biotherapeutics, Inc.) - Company Long-Term Debt|Long-Term Debt Volume adlainortye.com ANL|VERU: Company Long-Term Liabilities|tempesttx.com - Long-Term Debt|Company Long-Term Debt XLO (Xilio)|Renovaro Inc. (RENB) - Long-Term Debt Volume|Company Long-Term Liabilities muraloncology.com MURA|Kairos Pharma (KAPA) - Company Long-Term Loans and Borrowings|OKUR (OnKure Therapeutics, Inc.) - Company Long-Term Debts|Company Long-Term Debts CytoMed|CRIS: Company Long-Term Debts|Long-Term Indebtedness APLM (apollomicsinc.com)|Tharimmune Corp - Company Long-Term Debt|Advanced Biomed Inc. - Company Long-Term Liabilities|GNPX (Genprex, Inc.) - Company Long-Term Debt|CLDI: Long-Term Debt|Company Long-Term Debt Sunshine Biopharma SBFM|Xenetic Biosciences, Inc. (XBIO) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SLRX|Company Long-Term Liabilities Kitov Pharma|Company Long-Term Debts AONC|Company Long-Term Debts BGNE (beigene.com)|CKPT - Company Long-Term Debt|Company Long-Term Indebtedness Elevation Oncology Inc. ELEV|ICAD: Company Long-Term Debts|IKNA - Company Long-Term Liabilities|Company Long-Term Debts NTBL|VIRX (Viracta Therapeutics, Inc.) - Long-Term Debt|NAYA - Company Long-Term Debt|Company Long-Term Loans and Borrowings Ascentage Pharma Group International (AAPGV)